Jailendra Singh
Stock Analyst at Truist Securities
(1.07)
# 3,818
Out of 5,048 analysts
186
Total ratings
32.65%
Success rate
-21.23%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Reiterates: Buy | $235 → $265 | $213.88 | +23.90% | 17 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $22.73 | +58.38% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $44.39 | -16.65% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $168.79 | +38.63% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $594.02 | -26.60% | 5 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $37.03 | +37.73% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $18.43 | +46.50% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $6.72 | +138.10% | 7 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $66.95 | -8.89% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $50.34 | -4.65% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $8.14 | +10.57% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $24.76 | +13.09% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $3.31 | +66.16% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $5.09 | +47.35% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $32.99 | +39.44% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $292.72 | -28.26% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.41 | +34.49% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.81 | +702.17% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $5.18 | +150.97% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $3.45 | +1,146.38% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.86 | +739.16% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.06 | +94.17% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $190.22 | -69.51% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $3.81 | +1,081.10% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $820.29 | -59.40% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.68 | +144.57% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $28.19 | - | 3 | Jan 15, 2021 |
IQVIA Holdings
Oct 29, 2025
Reiterates: Buy
Price Target: $235 → $265
Current: $213.88
Upside: +23.90%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $22.73
Upside: +58.38%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $44.39
Upside: -16.65%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $168.79
Upside: +38.63%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $594.02
Upside: -26.60%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $37.03
Upside: +37.73%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $18.43
Upside: +46.50%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $6.72
Upside: +138.10%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $66.95
Upside: -8.89%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $50.34
Upside: -4.65%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $8.14
Upside: +10.57%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $24.76
Upside: +13.09%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $3.31
Upside: +66.16%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $5.09
Upside: +47.35%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $32.99
Upside: +39.44%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $292.72
Upside: -28.26%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.41
Upside: +34.49%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.81
Upside: +702.17%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $5.18
Upside: +150.97%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $3.45
Upside: +1,146.38%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.86
Upside: +739.16%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.06
Upside: +94.17%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $190.22
Upside: -69.51%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $3.81
Upside: +1,081.10%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $820.29
Upside: -59.40%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.68
Upside: +144.57%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $28.19
Upside: -